Drug Executive Collapses During Oval Office Press Conference
A press conference in the Oval Office was abruptly interrupted when a drug executive fainted while President Donald Trump announced a deal with pharmaceutical companies aimed at lowering obesity drug prices.
Incident Details
The event involved President Trump, Eli Lilly, and Novo Nordisk discussing an agreement to expand coverage and reduce costs for obesity treatments Zepbound and Wegovy. During the remarks, David Ricks, CEO of Eli Lilly, noticed someone collapse.
"Are you OK? Gordon, are you OK?"
David Ricks asked, as Gordon Findlay, identified by Getty Images as the global brand director for Novo Nordisk, suddenly fainted.
Immediate Response
Dr. Mehmet Oz, Administrator of the Centers for Medicare & Medicaid Services, quickly assisted Findlay as he collapsed to his knees. The press was then escorted out of the room and asked to leave.
President Donald Trump looks on as Administrator for the Centers for Medicare & Medicaid Services Dr. Mehmet Oz and others help a man identified as Gordon Findlay, who passed out during an event where Trump made a statement on lowering drug price.
Health and Human Services Secretary was also present during the incident.
Summary
The press conference ended prematurely due to the unexpected medical emergency involving a key pharmaceutical executive, underscoring the unpredictable nature of such events during high-profile announcements.
Author’s Summary: During President Trump’s announcement on drug price reductions, a Novo Nordisk executive fainted, prompting quick intervention by Dr. Mehmet Oz and abruptly ending the press event.